![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Friday, July 31, 2020 11:54:18 AM
Revive Therapeutics updates on potential COVID-19 treatment, and its oral form of magic mushrooms
Revive Therapeutics Ltd. (CSE: RVV) (OTCMKTS: RVVTF) CEO Michael Frank and Psilocin Pharma Founder Derrick Welsh explain to Proactive how the Toronto-based company is currently advancing to a Phase 3 clinical trial to treat the coronavirus with a rheumatoid arthritis therapy, in addition to its efforts to advance its oral dosage forms of ...
https://video.search.yahoo.com/search/video?fr=ymyy-t-s&p=revive+therapeutics+news#id=1&vid=d0348bfeea10f44f390822e15a137bca&action=click
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM